首页> 外国专利> NUCLEAR MAGNETIC RESONANCE DIAGNOSTIC AGENT, AND METHOD FOR DETECTING OR DIAGNOSING STATE OF CELL, TISSUE OR ORGAN IN SUBJECT USING SAME

NUCLEAR MAGNETIC RESONANCE DIAGNOSTIC AGENT, AND METHOD FOR DETECTING OR DIAGNOSING STATE OF CELL, TISSUE OR ORGAN IN SUBJECT USING SAME

机译:核磁共振诊断剂以及使用该方法检测或诊断对象中细胞,组织或器官状态的方法

摘要

[Problem];To provide a nuclear magnetic resonance diagnostic agent that has a lower toxicity to organisms and reduced side effects and yet has a site specificity toward a specific cell, tissue, organ, etc.;[Solution];When ALA or an ALA derivative is administered in vivo, a metabolite thereof is accumulated in a specific cell, tissue, organ, etc. Focusing on this phenomenon, a nuclear magnetic resonance analysis was performed on a site wherein the metabolite of ALA that had been administered in vivo would be possibly accumulated. As a result, it was surprisingly found that ALA and an ALA derivative are useful as a diagnostic agent whereby the aforesaid problem can be solved.
机译:[问题];提供一种对生物具有较低的毒性和减少的副作用,但对特定细胞,组织,器官等具有位点特异性的核磁共振诊断剂; [解决方案];当ALA或ALA时体内施用该衍生物,其代谢产物积聚在特定的细胞,组织,器官等中。针对这种现象,在其中体内施用了ALA代谢产物的部位进行了核磁共振分析。可能积累。结果,令人惊讶地发现,ALA和ALA衍生物可用作诊断剂,从而可以解决上述问题。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号